Arnold Schwarzenegger's 'serious' valve disease that he was born with - explained
ARNOLD SCHWARZENEGGER is the ultimate action man with films like The Terminator, Red Heat and Kindergarten Cop in his back catalogue. A few years ago, the Hollywood "tough guy" worried fans as he had major heart surgery, followed by a second operation a couple of years after. Since his heart surgeries, Schwarzenegger has made some drastic lifestyle changes in order to look after his health. (Source: Daily Express - Health)
Source: Daily Express - Health - July 17, 2022 Category: Consumer Health News Source Type: news

Surgery After TAVR: Waiting a Month or More Not Really Better
(MedPage Today) -- People didn't have to wait long after transcatheter aortic valve replacement (TAVR or TAVI) to safely undergo noncardiac surgery, though suboptimal device performance should give pause for another operation, a study suggested... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - July 8, 2022 Category: Surgery Source Type: news

Bionic valve may spare heart patients from major surgery
The JenaValve Trilogy implant, which can be fitted in under an hour using local anaesthetic, is designed to treat aortic regurgitation, a condition that starves the body of oxygenated blood. (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2022 Category: Consumer Health News Source Type: news

TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain
(MedPage Today) -- CHICAGO -- Newer devices don't mean that the maturing transcatheter aortic valve replacement (TAVR) field has completely solved its problem with conduction disturbances requiring permanent pacemaker (PPM) implantation, according... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 12, 2022 Category: Cardiology Source Type: news

TAVR Devices Keep Changing -- Is This Really Helping Patients?
(MedPage Today) -- CHICAGO -- Tweaks made to Medtronic's CoreValve transcatheter heart valve (THV) line in the last few years have tracked with some improved outcomes after transcatheter aortic valve replacement (TAVR), but it's still not clear... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 10, 2022 Category: Cardiology Source Type: news

Warning: The mineral supplement linked to a 'near tripling' risk of open heart surgery
MINERAL supplements may seem like a no-brainer but they can present hidden health risks. Indeed, one study tied a popular mineral supplement to a "near tripling" risk of aortic valve replacement - a type of open heart surgery used to treat problems with the heart's aortic valve. (Source: Daily Express - Health)
Source: Daily Express - Health - June 10, 2022 Category: Consumer Health News Source Type: news

Exercise Low Risk After Bicuspid Aortic Valve Aneurysm Repair Exercise Low Risk After Bicuspid Aortic Valve Aneurysm Repair
Patients who had surgery to repair an aortic aneurysm related to a bicuspid aortic valve are at low risk of future aneurysm events even from endurance exercise, a new study suggests.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 9, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news

Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
MitraClip, manufactured by Abbott Abbott today announced late-breaking data for MitraClip ™, the world's first transcatheter edge-to-edge repair (TEER) device, and TriClip™, a first-of-its kind minimally invasive tricuspid heart valve repair device. The data reinforce the capabilities of the company's structural heart solutions for both mitral and tricuspid regurgitation (MR and TR) across a broad range of patient groups battling leaky heart valves (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - June 8, 2022 Category: Cardiology Source Type: news

Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
- New results demonstrate MitraClip ™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) (Source: Abbott.com)
Source: Abbott.com - June 8, 2022 Category: Pharmaceuticals Source Type: news

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

TAVR for Aortic Regurgitation Off to a Good Start in the Real World
(MedPage Today) -- PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction disturbance risk leave room for... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 21, 2022 Category: Cardiology Source Type: news

Device Type Matters for Valve-in-Valve TAVR in Small Anatomies
(MedPage Today) -- PARIS -- For people with failed surgical aortic valves, the choice of device for a subsequent valve-in-valve transcatheter aortic valve replacement (TAVR) had implications for valve hemodynamics down the line, researchers showed... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 20, 2022 Category: Surgery Source Type: news

TAVR Stays Its Course as 10-Year Durability Data Trickle In
(MedPage Today) -- PARIS -- Extended follow-up data were reassuring for transcatheter aortic valve replacement (TAVR, or TAVI) durability beyond 10 years, investigators found. In the U.K. TAVI registry, there was a 5.9% incidence of severe structural... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - May 19, 2022 Category: Surgery Source Type: news

People with aortic stenosis may benefit from earlier valve replacement, study finds
People with a form of heart disease called aortic stenosis should undergo valve replacement surgery before symptoms first appear in order to avoid permanent damage, researchers said in an article published Tuesday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 17, 2022 Category: Consumer Health News Source Type: news

Calcium Supplements Linked to Worse Outcome in Aortic Stenosis Calcium Supplements Linked to Worse Outcome in Aortic Stenosis
Oral calcium supplementation was associated with lower survival and a greater need for aortic valve replacement in elderly patients with mild to moderate aortic stenosis, a new study finds.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 28, 2022 Category: Cardiology Tags: Cardiology News Source Type: news